Is there any relationship between serum sirtuin-1 level and neutrophil-lymphocyte ratio in hyperemesis gravidarum?

References

[1] Ayyavoo A, Derraik JG, Hofman PL, Cutfield WS. Hyperemesis gravidarum and long-term health of the offspring. Am J Obstet Gynecol. 2014;210:521–5.10.1016/j.ajog.2013.11.035Search in Google Scholar PubMed

[2] Helseth R, Ravlo M, Carlsen SM, Vanky EE. Androjens and hyperemesis gravidarum: a case-controlstudy. Eur J ObstetGynecol Reprod Biol. 2014;175:176–1.Search in Google Scholar

[3] Yoneyama Y, Suzuki S, Sawa R, Araki T. Plasma adenosine concentrations increase in women with hyperemesis gravidarum. Clin Chim Acta. 2004;342:99–103.10.1016/j.cccn.2003.12.004Search in Google Scholar PubMed

[4] Kong S, Yeung P, Fang D. The Class III histone deacetylase sirtuin 1 in immune suppression and its therapeuticpotential in rheumatoid arthritis. J Genel Genomics. 2013;20:347–54.10.1016/j.jgg.2013.04.001Search in Google Scholar PubMed PubMed Central

[5] Haberland M, Montgomery RL, Olson EN. Themanyroles of histone deacetylases in development and physiology: implications for disease and therapy. Nat Rev Genet. 2009;10:32–42.10.1038/nrg2485Search in Google Scholar PubMed PubMed Central

[6] Shakespear MR, Halili MA, Irvine KM, Fairlie DP, Sweet MJ. Histone deacetylases as regulators of inflammation and immunity. Trends Immunol. 2011;32:335–43.10.1016/j.it.2011.04.001Search in Google Scholar PubMed

[7] Osborne B, Cooney GJ, Turner N. Are sirtuin deacylase enzymes important modulators of mitochondrial energy metabolism? Biochim Biophys Acta. 2014;1840:1295–302.10.1016/j.bbagen.2013.08.016Search in Google Scholar PubMed

[8] Hwang JW, Yao H, Caito S, Sundar IK, Rahman I. Redox regulation of SIRT 1 in inflammation and cellular senescense. Free Radic Biol Med. 2013;61C:95–110.10.1016/j.freeradbiomed.2013.03.015Search in Google Scholar PubMed PubMed Central

[9] Schug TT, Li X. Sirtuin 1 in lipid metabolism and obesity. Ann Med. 2011;43:198–211.10.3109/07853890.2010.547211Search in Google Scholar PubMed PubMed Central

[10] Lomd DJ, Laurent G, Haigis MC. Sirtuins regulate aspects of lipid metabolism. Biochim Biophys Acta. 2010;1804:1652–7.10.1016/j.bbapap.2009.11.021Search in Google Scholar PubMed

[11] Seretis C, Gourgiotis S, Gemenetzis G, Seretis F, Lagoudianakis E, Dimirrakopoulos G. The significance of neutrophil/lymhocyte ratio as a possible marker of under lying papillary micro carcinomas in trathyroidal goiters: a pilot study. Am j Surg. 2013;205:691–6.10.1016/j.amjsurg.2012.08.006Search in Google Scholar PubMed

[12] Yilmaz H, Ucan B, Sayki M, Unsal I, Sahin M, Ozbek M, et al. Usefulness of the neutrophil-to-lymphocyte ratioto prediction of type 2 diabetes mellitus in morbid obesity. Diabetes Metab Syndr. 2014. pii:S1871-4021(14)00021-6. Doi:10.1016/j.dsz.2014.04.009.10.1016/j.dsz.2014.04.009Search in Google Scholar

[13] Matthews DR, Hosker JP, Rudenski AS, Naylor BA, Treacher DF, Turner RC. Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia. 1985;28:412–9.10.1007/BF00280883Search in Google Scholar

[14] Silva JP, Wahlestedt C. Role of Sirtuin 1 in metabolic regulation. Drug Discov Today. 2010;15:781–91.10.1016/j.drudis.2010.07.001Search in Google Scholar

[15] Gillum MP, Erion DM, Shulman GI. Sirtuin-1 regulation of mammalian metabolism. Trends Mol Med. 2011;17:8–13.10.1016/j.molmed.2010.09.005Search in Google Scholar

[16] Rodgers JT, Lerin C, Haas W, Gygi SP, Spiegelman BM, Puigserver P. Nutrient control of glucose homeostasis through a complex of PGC-1 alpha and SIRT1. Nature. 2005;434:113–8.10.1038/nature03354Search in Google Scholar

[17] Schwer B, Verdin E. Conserved metabolic regulatory functions of sirtuins. Cell Metab. 2008;7:104–12.10.1016/j.cmet.2007.11.006Search in Google Scholar

[18] Wang Q, Sun X, Li X, Dong X, Li P, Zhao L. Resveratrol attenuates intermittent hypoxia-induced insülin resistance in rats: involvement os Sirtuin 1 and the phosphatidylinositol-4,5-bisphosphate 3-kinase/AKT pathway. Mol Med Rep. 2015;11:151–8.10.3892/mmr.2014.2762Search in Google Scholar

[19] Engın-Ustun Y, Tonguç E, Var T, Deever R, Yilmaz N, Danişman N, et al. Vaspin and C-reactive protein levels in hyperemesis gravidarum. Eur Rev Med Pharmacol Sci. 2013;17:138–140.Search in Google Scholar

[20] Kuscu NK, Yildirim Y, Koyuncu F, Var A, Uyanik BS. Inteleukin-6 levels in hyperemesis gravidarum. Arch Gynecol Obstet. 2003;269:13–5.10.1007/s00404-002-0412-6Search in Google Scholar

[21] Kaplan PB, Gucer F, Sayin NC, Yuksel M, Yuce MA, Yardim T. Maternal serum cytokine concentrations in women with hyperemesis gravidarum in the first trimester of pregnancy. Fertil Steril. 2003;79:498–502.10.1016/S0015-0282(02)04699-XSearch in Google Scholar

[22] Kurt KR, Güler A, Silfeler DB, Özçil MD, Karateke A, Hakverdi AU. Relationship of inflammatory markers with both presence of severity of hyperemesis gravidarum. Ginekol Pol. 2014;85:589–3.10.17772/gp/1776Search in Google Scholar PubMed

[23] Zahorec R. Ratio of neutrophil to lymphocyte counts- rapid and simple parameter of systemic inflammation and stress in critically ill. Bratisl Lek Listy. 2001;102:5–14.Search in Google Scholar

[24] Xia Y, Guo XG, Ji TX, Chen Q. Neutrophil count to lymphocyte count ratio is a potential ındex for bacteremia in adult. Life Sci J. 2014;11:172–7.Search in Google Scholar

[25] Hu ZD, Sun Y, Guo J, Huang YL, Qin BD, Gao Q, et al. Red blood cell distribution width and neutrophil/lymphocyte ratio are positively correlated with disease activity in primary Sjogren’s sydrome. Clin Biochem. 2014;47:287–90.10.1016/j.clinbiochem.2014.08.022Search in Google Scholar PubMed

[26] Coskun BN, Oksuz MF, Ermurat S, Tufan AN, Orucoglu N, Dogan A, et al. Neutrophil lymphocyte ratio can be a valuable marker in defining diseasea ctivity in patients who have strated antitumor necrosis factor (TNF) drugs for ankylosing spondylitis. Eur J Rheumatol. 2014;1:101–5.10.5152/eurjrheumatol.2014.034Search in Google Scholar PubMed PubMed Central

[27] Kurtoglu E, Kokcu A, Celik H, Tosun M, Malatyalioglu E. May ratio of neutrophil to lymphocyte be useful in predicting the risk of developing preeclampsia? A pilot study. J Matern Fetal Neonatal Med. 2015;28:97–9.10.3109/14767058.2014.905910Search in Google Scholar PubMed

[28] Yavuzcan A, Cağlar M, Ustün Y, Dilbaz S, Ozdemir I, Ozbilgec S, et al. Mean platelet volüme, neutrophil-lymphocyte ratio and platelet-lymphocyte ratio in severe preeclamsia. Ginekol Pol. 2014;85:197–203.10.17772/gp/1713Search in Google Scholar

[29] Yilmaz H, Celik HT, Namuslu M, Inan O, Onaran Y, Karakurt F, et al. Benefits of the neutrophil-to-lymphocyte ratio for the prediction of gestational diabetes mellitus in pregnant women. Exp Clin Endocrinol Diabetes. 2014;122:39–43.10.1055/s-0033-1361087Search in Google Scholar PubMed